• Home
  • » 
  • Reports
  • » 
  • Biologics Fill Finish Manufacturing Mark...

Fill Finish Manufacturing Market

Biologics Fill Finish Manufacturing Market (3rd Edition) by Type of Packaging Containers, Type of Biologics, Scale of Operation, Company Size, Key Therapeutic Areas, Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Lowest Price Guaranteed From USD 4,799

  • Published
    January 2023

  • Pages
    659

  • View Count
    38419

  • Buy Now

Example Insights

The image provides context of biologics fill finish manufacturing market. The requirement for extensive capital investment and complex infrastructure for in-house filling of biologics has prompted biopharmaceutical companies to leverage the expertise of service providers for fill / finish of biologics This image highlights inputs given by industry stakeholders during interviews conducted. The independent opinion of representatives from prominent companies corroborate the fact that the opportunities associated with contract fill / finish services for biologics are steadily rising The image provides a list of fill finish manufacturing companies. Over 175 players worldwide claim to have the necessary capabilities to offer fill / finish services for a variety of biological interventions This image highlights biologics fill finish manufacturing market landscape. The market is highly fragmented, featuring the presence of both new entrants and well-established players, offering fill / finish services for different types of packaging containers at various scales of operation
The snapshot looks at the geographical distribution of fill finish manufacturing companies. To cater to the evolving needs of clients / sponsors across the world, companies have established presence in multiple regions around the globe; Europe is the hub for fill / finish facilities The image looks at the competitive landscape of fill finish manufacturing companies. In pursuit of building a competitive edge, stakeholders are actively upgrading their existing capabilities and enhancing their respective service offerings to comply with the evolving industry benchmarks This image highlights varios expansion initiatives undertaken by fill finish manufacturing companies. Over the past few years, the field has witnessed a notable increase in expansion and partnership activity for biologics fill / finish capabilities This snapshot looks at the overall fill finish manufacturing capacity across the world. Majority of the fill / finish capacity is installed in facilities established by large players; more than 40% of the available capacity is installed in facilities located in Europe
The image provides a view on the likely demand for fill finish in the coming years. By 2035, over 50% of the demand for fill / finish services is likely to be generated from filling of vials; a sizeable proportion of the current demand is being generated from commercialized drug products This image provides demand vs supply analysis for fill finish contract manufacturing. In order to meet the anticipated demand growth in the foreseen future, we expect stakeholders to continue to expand their facilities to further strengthen the supply-side This infographic looks at the fill finish manufacturing market size. The overall opportunity in biologics fill / finish services market is likely to grow at a CAGR of ~10%; it is expected to be well distributed across different scales of operation, types of biologics and packaging containers The image provides detials on various segments within the fill finish manufacturing market. In the long-term, the majority share of revenues is likely to be driven by players offering fill/finish services for products intended for treating oncological and infectious diseases

 

Report Description

In order to meet the anticipated future demand for biologics fill / finish services in the American and European markets, contract service providers based in these regions have made significant investments in accruing additional capacity for drug product manufacturing and fill / finish

-- Chief Commercial Officer, large-sized company

Biologics Fill Finish Manufacturing Overview

The biologics fill finish manufacturing market, representing the opportunity for contract manufacturers, is estimated to be USD 4 billion in 2022. The global market size is anticipated to grow at a CAGR of 8.4% during the forecast period. The advent of biologics marked the beginning of a new era in the pharmaceutical industry. Over time, the growing promise of biopharmaceuticals has captured the interest of various industry and academic stakeholders. Currently, more than 200 biologics are commercially available and over 10,000 candidates are under clinical evaluation. With the increasing demand and diversity of biologics, an increase in the demand for production capacity and aseptic fill finish operations has been observed. Fill/finish refers to the process of filling the final drug products in sterile packaging containers (including vials, syringes, ampoules and cartridges). Of all the steps involved in the production of biologics, fill-finish is amongst the most critical steps and a heavily outsourced operation. In fact, even a minute error during the fill/finish process can lead to microbial contamination, which can subsequently result in the loss of drug product, production delays and, most importantly, pose risk to the patient’s health. As a result, various stakeholders are turning to contract manufacturing organizations for their fill/finish related requirements and necessary infrastructure, to ensure the development of quality drug products.  Driven by the growing demand for biopharmaceuticals, the biologics fill finish manufacturing market is anticipated to witness substantial growth during the forecast period.

Key Market Insights

The Biologics Fill Finish Manufacturing Market (3rd Edition) by Type of Packaging Containers (Ampoules, Cartridges, Syringes and Vials), Type of Biologics (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and  Other Biologics), Scale of Operation (Preclinical / Clinical and Commercial), Company Size (Large, Mid-sized and Small), Key Therapeutic Areas (Autoimmune Disorders, Oncological Disorders, Cardiovascular Disorders, Infectious Diseases and Other Disorders), Geographical Regions (North America, Europe, Asia Pacific, Middle East and North Africa and Latin America): Industry Trends and Global Forecasts, 2022-2035 market report features an extensive study of the current market landscape, market size, market forecast and future opportunities associated with the biopharmaceuticals fill finish market, during the given forecast period. The research report highlights efforts of several contract manufacturing organizations engaged in this rapidly emerging segment of the biopharmaceuticals manufacturing industry. Key takeaways of the biologics fill finish manufacturing market are briefly discussed below.

Biologics Fill Finish Manufacturing: Market Landscape of Contract Manufacturing Organizations

With the growing pipeline of biologics, the demand for contract services for development and fill/finish has increased. Currently, close to 180 companies offer fill finish manufacturing services for a wide range of biologics. In terms of geographical presence, we have identified more than 350 fill-finish facilities of these contract manufacturing organizations. Majority of the facilities are located in Europe, followed by North America and Asia Pacific.
 
Nearly 70% of the companies have the capability to operate at all the scales of operation from preclinical to commercial. Additionally, the companies have capability to work with different types of biologics including peptides, antibodies, vaccines, cell therapy, gene therapy, nucleic acids, plasmid DNA, antibody drug conjugates, biosimilars and others. 

Market Trends Analysis: Partnerships by Companies to Fulfil the Growing Demand for Fill-Finish Manufacturing

The biopharmaceutical industry has witnessed substantial number of partnerships and collaborations between drug developers and fill/finish contract manufacturing organizations over the last few years. The COVID 19 pandemic also led to an increase in the demand for fill finish of vaccines, leading to a rise in the number of service agreements. For fulfilling the demand for its COVID vaccine in Europe, Pfizer and BioNTech collaborated with Delpharm, Thermo Fisher Scientific and more companies for fill&finish operations. Similarly, Moderna entered into service agreements with Catalent, ROVI, Thermo Fisher, Recipharm, Samsung Biologics and other companies to fulfill the fill&finish demand for its COVID vaccine. We believe that service providers are likely to continue undertaking similar initiatives in the short-term to consolidate their presence in this field, distinguish themselves from the competition and cater to the diversified needs of their clientele. However, as the demand for fill/finish of pandemic vaccine decreases in the long-term, the contract manufacturing organizations will enter a phase of increased competition. 

Global Market Size of Fill Finish Manufacturing for Biopharmaceuticals

The biologics fill-finish manufacturing market opportunity for the CMOs is estimated to be USD 4 billion in 2022. With outsourcing being increasingly accepted as a viable / beneficial business model and the anticipated market growth for biologics, the opportunity for fill/finish contract manufacturers is expected to grow at a steady pace over the forecast period. Another key driver for the market growth for outsourcing of fill finish services of biologics is the rise in the number of small biopharmaceutical drug developers. The last few years have seen a rise in the number of investor funded startups for cell and gene therapy. As these drug developers move their products to clinical stages, the demand for outsourcing of biologic manufacturing and fill finish services will witness a healthy market growth.

Europe a Hub for Biologics Fill Finish; North America to be the Fastest Growing Market

Currently, Europe and Asia Pacific capture over 70% share of the overall biologics fill finish manufacturing market. In recent years, demand for fill finish services in Asia Pacific region has observed a tremendous increase. However, in the coming years, owing to the anticipated drug approvals, North America is likely to grow at a much faster rate as compared to other geographies.

Future Outlook:  Contract Manufacturers to Undertake Expansions in Order to Fill the Demand Supply Gap

A number of CMO / CDMOs have taken initiatives to expand their existing facilities and incorporate advanced technologies in order to meet the growing demand for fill/finish services, reduce cost of operation / increase efficiency, and comply to evolving safety and regulatory requirements. This market report analyzes the current installed capacity with the contract manufacturers for fill finish of biopharmaceuticals and the demand for commercial biologics till 2035. The current installed capacity is sufficient to meet the industry demand, but based on our data analysis this scenario is likely to change at the earliest by 2027. In order to meet the anticipated demand growth during the forecast period, we expect the contract manufacturers to continue to expand their facilities to strengthen the supply side.

Leading Fill Finish Manufacturing Companies Offering Services for Biologics

Examples of key companies engaged in this industry (which have also been profiled in this report) include (in alphabetical order), AbbVie Contract Manufacturing, Asymchem, BioXcellence, BioPharma Solutions, BioReliance, Catalent Biologics, Charles River Laboratories, Fareva, Fresenius Kabi, GlaxoSmithKline, Hetero Drugs, Intas Pharmaceuticals, Lonza, Patheon, Pierre Fabre, Recipharm, Samsung Biologics, Syngene, Takara Bio, Wacker Biotech, and WuXi Biologics. This biologics fill finish manufacturing market report includes an easily searchable excel database of all the contract manufacturing organizations that have capability to fill finish biologics worldwide.

Recent Developments in Fill Finish Manufacturing of Biologics

Several recent developments have taken place in the field of fill/finish manufacturing of biologics. We’ve outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that we’ve outlined in our analysis.

  • In July 2023, Syngene announced the acquisition of Stelis Biopharma’s biologics manufacturing facility having installed capacity of 20,000 liters. 
  • In June 2023, Catalent announced the expansion of its integrated development, manufacturing and supply solution, OneBio® Suite across various range of biologic modalities. 
  • In May 2023, Aurigene Pharmaceutical Services announced the expansion of its biologics CDMO capacity by building a manufacturing facility for therapeutic proteins, antibodies, and viral vectors. 
  • In May 2023, Thermo Fisher announced the opening of a sterile fill finish facility in Singapore. The facility has a fully automated fill-finish line for small molecules and biologics. It allows the company to conduct end-to-end vaccine manufacturing in Singapore.
  • In May 2023, Moderna announced the establishment of a strategic partnership with Novocol. The company mentioned that it will outsource the fill finish operations of vaccines manufactured at Moderna’s Laval-based mRNA facility to latter company.
  • In April 2023, Meridian Medical Technologies announced the investment of USD 100 million in order to expand its sterile fill-finish capabilities in Missouri, US. The new facility is anticipated to support company’s sterile fill finish capabilities and increased production of drug-device combination products.

Scope of the Report

The market research report presents an in-depth analysis of the various firms / contract manufacturing organizations that are engaged in this biologics fill finish manufacturing market, across different segments, as defined in the table below:

Market Segments Details

Base Year

2021

Forecast Period

2022-2035

Market Size 2022

$ 4 billion

CAGR

8.4%

Type of Packing Containers
  • Vials
  • Syringes
  • Ampoules
  • Cartridges
Type of Biologics
  • Vaccine
  • Recombinant Proteins
  • Antibodies
  • Oligonucleotides
  • Gene Therapies
  • Cell Therapies
  • Other Biologics

Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and North Africa
  • Latin America
Therapeutic Area
  • Preclinical / Clinical
  • Commercial
Company Size
  • Large
  • Mid-sized
  • Small

Geographical Region
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and North Africa
  • Latin America

 

The market report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry. Amongst other elements, the market research report includes:

  • A summary of the key insights captured in our research, offering a high-level view on the likely evolution of the biologics fill/finish contract manufacturing market in the short to mid-term, and long term.
  • A general introduction to biopharmaceuticals and contract manufacturing, featuring a detailed discussion on the need for outsourcing within the biopharmaceutical industry and key operations outsourced by the biologics drug developers, including fill/finish. It also provides information on the key considerations for selecting a fill-finish contract manufacturing organization, along with the benefits and risks associated with outsourcing fill/finish operations.
  • A detailed review of the overall landscape of the companies offering biopharmaceuticals fill finish services, along with analyses based on a number of relevant parameters, such as year of establishment, company size, location of headquarters, location of fill/finish facilities, type of packaging container(s) used (ampoules, cartridges, syringes and vials),  type of biologic(s) manufactured (antibody drug conjugates, antibodies, biosimilars, cell therapies, gene therapies, oligonucleotides, peptides / proteins, vaccines, viral products, and others), scale of operation (preclinical, clinical and commercial), type of additional drug product-related service(s) offered (lyophilization, labeling, quality testing, storage and distribution services) and including details relared to companies.
  • A detailed competitiveness analysis of the biologics fill/finish contract manufacturing organizations headquartered in different geographies (North America, Europe, Asia-Pacific ad Rest of the World) and offering services across various packaging container(s), based on supplier strength (in terms of years of experience and company size), service strength (considering type of biologic(s) manufactured, scale of operation and type of packaging container(s) used) and service diversity (including number of additional drug product-related service(s) offered and number of facilities).     
  • Elaborate profiles of key companies based in North America, Europe and Asia Pacific. Each profile provides an overview of the company, business description (information on its service offerings), fill-finish facilities, financial information (if available), details on partnerships, expansions, recent awards and accolades, and an informed future outlook. 
  • A detailed analysis of the various partnerships and collaborations established by stakeholders in this industry since 2013. It includes a brief description of the partnership models (including service agreement, service alliance, product integration agreement and joint venture and acquisition) adopted by stakeholders in the fill-finish manufacturing market. Further, it comprises of analysis based on year of partnership, scale of operation, type of service(s) offered, type of biologic(s) involved, type of process(es) involved and location of the facilities / headquarters. It also highlights the most active companies (in terms of number of partnerships) in the market.  
  • A detailed analysis of the expansions undertaken by various contract manufacturing organizations to enhance biologics fill/finish capabilities, based on various parameters, including year of expansion, type of expansion, geographical location of the facility, type of packaging container(s) involved, scale of operation (as mentioned in the expansion terms), type of service(s) offered, type of biologic(s) involved, and expansion details (in terms of new area added to the existing facilities). It also highlights the most active companies (in terms of number of instances) in the fill-finish manufacturing market.
  • A comprehensive analysis of the global biologics fill&finish capacity, by taking into consideration the container processing capacities of various fill/finish service providers (as available on respective company websites). The global biopharmaceuticals fill/finish capacity has been distributed across number of packaging units, type of packaging container (ampoules, cartridges, syringes and vials), company size of the manufacturer (small, mid-sized and large), scale of operation (preclinical / clinical and commercial) and location of headquarters (North America, Europe, Asia Pacific and Middle East and North Africa) and location of fill/finish facility (North America, Europe, Asia Pacific and Middle East and North Africa and Rest of the World).
  • An estimate of the annual demand for fill-finish manufacturing for biologics (in terms of number of units of packaging container), based on various relevant parameters, such as target patient population, dosing frequency, dose strength, type of packaging container and volume of the packaging container of the abovementioned products. 
  • An analysis on the key performance indicators of service providers based on the information available for top ten biopharmaceutical players on various public platforms, as well as inputs obtained from primary research.
  • A regional capability assessment framework, which compares the biologics fill&finish capability across key geographies, based on a number of parameters, such as the number of biologics fill/finish service providers, number of biologics fill/finish facilities, number of biologics fill&finish partnerships inked in that particular geographical region, number of facility expansions and installed biologic fill&finish capacity in that particular geographical region.
  • A discussion on the potential growth drivers for the biologics fill finish manufacturing market, takes into consideration the opportunities associated with the growing biopharmaceutical pipeline, increase in outsourcing of fill/finish operations, rising focus on self-administration of drugs / therapies and opportunities in the Asia Pacific region.
  • A case study focused on use of robotic systems in fill/finish operations. It provides a list of equipment used by the service providers (wherever specified) for fill&finish operations, highlighting the purpose of robotics in various manufacturing operations. It also includes a list of companies providing robots for use in manufacturing processes carried in the pharmaceutical industry.
  • A case study on the use of ready to use packaging components in the aseptic fill/finish operations. It also provides a list of suppliers providing ready-to-use components.

One of the key objectives of this fill finish manufacturing market report was to estimate the current market size and the future opportunity in the biologics fill-finish manufacturing market over the forecast period. Based on multiple parameters, such as growth of the overall biopharmaceutical market, cost of goods sold, direct manufacturing costs, share of other manufacturing costs and outsourcing trends related to fill/finish operations, we have provided an informed estimate of the likely evolution of the market in the short to mid-term and long term, for the forecast period 2022-2035. In order to provide a detailed future outlook, year-wise projections of the current and future opportunity have been further segmented on the basis of type of packaging containers (ampoules, cartridges, syringes and vials), type of biologics (antibodies, cell therapies, gene therapies, oligonucleotides, recombinant proteins, vaccines and  other biologics), key therapeutic areas (autoimmune disorders, oncological disorders, cardiovascular disorders, infectious diseases and other disorders), scale of operation (preclinical / clinical and commercial), company size (large, mid-sized and small), and key geographical regions, (North America, Europe, Asia Pacific, Middle East and North Africa, and Latin America). To account for the uncertainties in the market and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.
    
The opinions and insights presented in this biologics fill finish manufacturing market report are backed by a deep understanding of key insights generated from both secondary and primary research. The perceptions presented in this market analysis were also influenced by discussions held with senior stakeholders in the industry. The market report features detailed transcripts of interviews held with the following industry and non-industry players:

  • Gregor Kawaletz (Chief Commercial Officer, IDT Biologika)
  • Matt Delaney (Vice President Business Development & Marketing, ‎Cytovance Biologics)
  • Purushottam Singnurkar (Research Director and Head of Formulation Development, Syngene International)
  • Ales Sima (Business Development Manager, Oncomed Manufacturing) 
  • Amit Chandra (Technology Watch Manager, Yposkesi)
  • Jos Vergeest (International Business Developer, HALIX)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market research report are in USD, unless otherwise specified.

Frequently Asked Questions

Question 1: What are fill finish services?

Answer: Fill/finish refers to the process of filling the final drug products in sterile packaging containers (including vials, syringes, ampoules and cartridges) and preparing them for distribution.

Question 2: What is the fill finish process in pharma?

Answer: Fill-finish process includes container preparation, closure preparation, sterilization, filling, capping, sealing and storage.

Question 3: What is the global market size for biologics fill finish manufacturing services?

Answer: The global market size of biologics fill finish manufacturing is estimated to be USD 4 billion in 2022.

Question 4: What is anticipated market growth for biologics fill finish manufacturing services?

Answer: The global biologics fill finish manufacturing market is anticipated to grow at a CAGR of over 8% during the forecast period 2023-2035.

Question 5: Which regional market segment has majority of the biologic fill/finish facilities?

Answer: In terms of number of fill&finish facilities with capability for biologics, Europe is the leading geographical segment with 40% of all the facilities located in the region.

Question 6: In terms of packaging containers, which segment holds the largest market share of biologic fill finish manufacturing market?

Answer: In the year 2022, fill finish of biologics in vials holds the largest market share.

Question 7: Which partnership models are most commonly adopted by stakeholders in this industry?

Answer: In 2022, majority of the partnerships signed between industry stakeholders were service agreements.

Question 8: What types of expansion initiatives are being undertaken by contract manufacturers in the biologics fill finish manufacturing market?

Answer: Post 2019, 54% of the expansions in biologics fill finish manufacturing industry were capacity expansions.

Question 9: Who are the leading contract manufacturing organizations offering biologics fill finish services?

Answer: Some of the leading contract manufacturers engaged in this industry (which have also been profiled in this report) include (in alphabetical order), AbbVie Contract Manufacturing, Asymchem, BioXcellence, BioPharma Solutions, BioReliance, Catalent Biologics, Charles River Laboratories, Fareva, Fresenius Kabi, GlaxoSmithKline, Hetero Drugs, Intas Pharmaceuticals, Lonza, Patheon, Pierre Fabre, Recipharm, Samsung Biologics, Syngene, Takara Bio, Wacker Biotech, and WuXi Biologics.

Contents

Table Of Contents

1 PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines

2 EXECUTIVE SUMMARY 

3 INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Biologics
3.3. Need for Outsourcing Biologics-related Operations
3.4. Introduction to Contract Manufacturing
3.5. Commonly Outsourced Operations in the Biopharmaceutical Industry
3.5.1. Biologics Fill/Finish Operations
3.6. Basic Guidelines for Selecting a Fill/Finish Service Provider
3.7. Advantages of Outsourcing Fill/Finish Operations
3.8. Risks and Challenges of Outsourcing Fill/Finish Operations 

4 BIOLOGICS FILL/FINISH SERVICE PROVIDERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Biologics Fill/Finish Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Location of Fill-Finish Facilities
4.2.5. Analysis by Type of Packaging Container(s) Used
4.2.6. Analysis by Type of Biologic(s) Manufactured
4.2.7. Analysis by Scale of Operation
4.2.8. Analysis by Additional Drug Product-related Services Offered
4.2.9. Biologics Fill/Finish Service Providers: Information on Fill-Finish Capacity 

5 COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology and Key Parameters 
5.3. Biologics Fill Finish Manufacturing Service Providers in North America
5.3.1. Players Offering Services for Ampoules
5.3.2. Players Offering Services for Cartridges
5.3.3. Players Offering Services for Syringes
5.3.4. Players Offering Services for Vials 
5.4. Biologics Fill Finish Manufacturing Service Providers in Europe
5.4.1. Players Offering Services for Ampoules
5.4.2. Players Offering Services for Cartridges
5.4.3. Players Offering Services for Syringes
5.4.4. Players Offering Services for Vials 
5.5. Biologics Fill Finish Manufacturing Service Providers in Asia Pacific and Rest of the World
5.5.1. Players Offering Services for Ampoules
5.5.2. Players Offering Services for Cartridges
5.5.3. Players Offering Services for Syringes
5.5.4. Players Offering Services for Vials

6 BIOLOGICS FILL FINISH CONTRACT MANUFACTURING COMPANIES IN NORTH AMERICA
6.1. Chapter Overview
6.2. AbbVie Contract Manufacturing
6.2.1. Company Overview
6.2.2. Service Portfolio
6.2.3. Financial Information
6.2.4. Recent Developments and Future Outlook 
6.3. BioPharma Solutions
6.3.1. Company Overview
6.3.2. Service Portfolio
6.3.3. Recent Developments and Future Outlook 
6.4. BioReliance
6.4.1. Company Overview
6.4.2. Service Portfolio
6.4.3. Financial Information
6.4.4. Recent Developments and Future Outlook
6.5. Catalent Biologics
6.5.1. Company Overview
6.5.2. Service Portfolio
6.5.3. Financial Information
6.5.4. Recent Developments and Future Outlook
6.6. Patheon
6.6.1. Company Overview
6.6.2. Service Portfolio
6.6.3. Financial Information
6.6.4. Recent Developments and Future Outlook
6.7. Charles River Laboratories
6.7.1. Company Overview
6.7.2. Fill / Finish Related Services
6.7.3. Financial Information
6.7.4. Recent Developments and Future Outlook 

7 BIOLOGICS FILL FINISH CONTRACT MANUFACTURING COMPANIES IN EUROPE
7.1. Chapter Overview
7.2. Boehringer Ingelheim BioXcellence
7.2.1. Company Overview
7.2.2. Service Portfolio
7.2.3. Financial Information
7.2.4. Recent Developments and Future Outlook
7.3. Lonza
7.3.1. Company Overview
7.3.2. Service Portfolio
7.3.3. Financial Information
7.3.4. Recent Developments and Future Outlook
7.4. Pierre Fabre
7.4.1. Company Overview
7.4.2. Service Portfolio
7.4.3. Financial Information
7.4.4. Recent Developments and Future Outlook
7.5. Recipharm
7.5.1. Company Overview
7.5.2. Service Portfolio
7.5.3. Financial Information
7.5.4. Recent Developments and Future Outlook
7.6. Wacker Biotech
7.6.1. Company Overview
7.6.2. Service Portfolio
7.6.3. Financial Information
7.6.4. Recent Developments and Future Outlook
7.7. Fareva
7.7.1. Company Overview
7.7.2. Fill / Finish Related Services
7.7.3. Recent Developments and Future Outlook
7.8. Fresenius Kabi
7.8.1. Company Overview
7.8.2. Fill / Finish Related Services
7.8.3. Financial Information
7.8.4. Recent Developments and Future Outlook
7.9. GlaxoSmithKline
7.9.1. Company Overview
7.9.2. Fill / Finish Related Services
7.9.3. Financial Information
7.9.4. Recent Developments and Future Outlook

8 BIOLOGICS FILL FINISH CONTRACT MANUFACTURING COMPANIES IN ASIA PACIFIC
8.1. Chapter Overview
8.2. Asymchem
8.2.1. Company Overview
8.2.2. Service Portfolio
8.2.3. Financial Information
8.2.4. Recent Developments and Future Outlook
8.3. Samsung Biologics
8.3.1. Company Overview
8.3.2. Service Portfolio
8.3.3. Financial Information
8.3.4. Recent Developments and Future Outlook
8.4. Syngene
8.4.1. Company Overview
8.4.2. Service Portfolio
8.4.3. Financial Information
8.4.4. Recent Developments and Future Outlook
8.5. Takara Bio
8.5.1. Company Overview
8.5.2. Service Portfolio
8.5.3. Financial Information
8.5.4. Recent Developments and Future Outlook
8.6. WuXi Biologics
8.6.1. Company Overview
8.6.2. Service Portfolio
8.6.3. Financial Information
8.6.4. Recent Developments and Future Outlook
8.7. Hetero Drugs
8.7.1. Company Overview
8.7.2. Fill / Finish Related Services
8.7.3. Recent Developments and Future Outlook
8.8. Intas Pharmaceuticals
8.8.1. Company Overview
8.8.2. Fill / Finish Related Services
8.8.3. Recent Developments and Future Outlook

9 PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Biologics Fill / Finish Service Providers: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Scale of Operation
9.3.4. Analysis by Type of Service(s) Offered
9.3.5. Analysis by Type of Process(es)
9.3.6. Analysis by Type of Biologic(s) Involved
9.3.7. Most Active Players: Analysis by Number of Partnerships
9.3.8. Analysis by Geographical Region
9.3.8.1. Intercontinental and Intracontinental Agreements

10 RECENT EXPANSIONS
10.1. Chapter Overview
10.2. Biologics Fill/Finish Service Providers: Recent Expansions
10.2.1. Analysis by Year of Expansion
10.2.2. Analysis by Type of Expansion
10.2.3. Analysis by Type of Packaging Container(s) Used
10.2.4. Analysis by Type of Service(s) Offered
10.2.5. Analysis by Type of Biologic(s) Involved and Scale of Operation
10.2.7. Most Active Players: Analysis by Number of Service(s) Offered
10.2.8. Analysis by Geographical Region
10.2.9. Expansions in North America: Analysis by Type of Service(s) Offered and Type of
 Biologic(s) Involved
10.2.10. Expansions in Europe: Analysis by Type of Service(s) Offered and Type of Biologic(s) Involved
10.2.11. Expansions in Asia Pacific: Analysis by Type of Service(s) Offered and Type of Biologic(s) Involved 

11 CAPACITY ANALYSIS
11.1. Chapter Overview
11.2. Assumptions and Methodology
11.3. Global Fill Finish Capacity (by Number of Units Filled)
11.3.1. Analysis by Type of Packaging Container
11.3.2. Analysis by Company Size
11.3.3. Analysis by Scale of Operation
11.3.4. Analysis by Location of Headquarters
11.3.5. Analysis by Location of Fill/Finish Facilities
11.4. Global Fill Finish Capacity (by Fill Volume)
11.4.1. Analysis by Type of Packaging Container
11.4.2. Analysis by Company Size
11.4.3. Analysis by Scale of Operation
11.4.4. Analysis by Location of Headquarters
11.4.5. Analysis by Location of Fill/Finish Facilities
11.5. Global Fill Finish Capacity for Ampoules (by Number of Units Filled)
11.5.1 Analysis by Company Size
11.5.2 Analysis by Scale of Operation
11.5.3. Analysis by Location of Headquarters
11.5.4 Analysis by Location of Fill/Finish Facilities
11.6. Global Fill Finish Capacity for Ampoules (by Fill Volume)
11.6.1. Analysis by Company Size
11.6.2. Analysis by Scale of Operation
11.6.3. Analysis by Location of Headquarters
11.6.4. Analysis by Location of Fill/Finish Facilities
11.7. Global Fill Finish Capacity for Cartridges (by Number of Units Filled)
11.7.1. Analysis by Company Size
11.7.2. Analysis by Scale of Operation
11.7.3. Analysis by Location of Headquarters
11.7.4. Analysis by Location of Fill/Finish Facilities
11.8. Global Fill Finish Capacity for Cartridges (by Fill Volume)
11.8.1. Analysis by Company Size
11.8.2. Analysis by Scale of Operation
11.8.3. Analysis by Location of Headquarters
11.8.4. Analysis by Location of Fill/Finish Facilities
11.9. Global Fill Finish Capacity for Syringes (by Number of Units Filled)
11.9.1 Analysis by Company Size
11.9.2 Analysis by Scale of Operation
11.9.3. Analysis by Location of Headquarters
11.9.4 Analysis by Location of Fill/Finish Facilities
11.10. Global Fill Finish Capacity for Syringes (by Fill Volume)
11.10.1. Analysis by Company Size
11.10.2. Analysis by Scale of Operation
11.10.3. Analysis by Location of Headquarters
11.10.4. Analysis by Location of Fill/Finish Facilities
11.11. Global Fill Finish Capacity for Vials (by Number of Units Filled)
11.11.1 Analysis by Company Size
11.11.2 Analysis by Scale of Operation
11.11.3. Analysis by Location of Headquarters
11.11.4. Analysis by Location of Fill/Finish Facilities
11.12. Global Fill Finish Capacity for Vials (by Fill Volume)
11.12.1. Analysis by Company Size
11.12.2. Analysis by Scale of Operation
11.12.3. Analysis by Location of Headquarters
11.12.4. Analysis by Location of Fill/Finish Facilities
11.13. Conclusion

12 DEMAND ANALYSIS
12.1. Chapter Overview
12.2. Assumptions and Methodology
12.3. Global Demand for Biologics Fill Finish Services
12.3.1. Analysis by Type of Packaging Container
12.3.2. Analysis by Type of Biologic
12.3.3. Analysis by Therapeutic Area
12.3.4. Analysis by Scale of Operation
12.3.5. Analysis by Company Size
12.3.6. Analysis by Geographical Location
12.4. Demand and Supply Analysis

13 KEY PERFORMANCE INDICATORS FOR BIOLOGIC MANUFACTURING AND FILL/FINISH

13.1. Chapter Overview
13.2. Biologics Manufacturing and Fill/Finish: Key Performance Indicators
13.2.1. Financial Indicators
13.2.1.1. Big Pharma Perspective
13.2.1.2. Contract Manufacturers’ Perspective
13.2.2. Process and Capability-related Indicators
13.2.2.1. Big Pharma Perspective
13.2.2.2. Contract Manufacturers’ Perspective
13.2.3. Market Reputation-related Indicators
13.2.3.1. Big Pharma Perspective
13.2.3.2. Contract Manufacturers’ Perspective
13.2.4. Other Important Performance Indicators
13.3.5. Conclusion 

14 REGIONAL CAPABILITY ASSESSMENT

14.1. Chapter Overview
14.2. Assumptions and Key Parameters
14.3. Biologics Fill/Finish Capabilities in North America
14.4. Biologics Fill/Finish Capabilities in Europe
14.5. Biologics Fill/Finish Capabilities in Asia Pacific and Rest of the World
14.6. Regional Analysis of Installed Biologics Fill Finish Capacity
14.7.  

15 MARKET SIZING AND OPPORTUNITY ANALYSIS

15.1. Chapter Overview
15.2. Forecast Methodology
15.3. Overall Biologics Fill Finish Manufacturing Market, 2022-2035 
15.3.1. Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Type of Packaging Container
15.3.2. Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Type of Biologic
15.3.3. Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Therapeutic Area
15.3.4. Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Scale of Operation
15.3.5. Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Company Size
15.3.6. Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Geographical Region
15.3.5.1 Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Countries
15.3.5.2. Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Type of Packaging Container
15.3.5.3. Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Type of Biologic
15.3.5.4. Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Therapeutic Area
15.3.5.5. Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Scale of Operation
15.3.5.6. Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Company Size
15.3.5.7. Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Countries
15.3.5.8. Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Type of Packaging Container
15.3.5.9. Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Type of Biologic
15.3.5.10. Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Therapeutic Area
15.3.5.11. Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Scale of Operation
15.3.5.12. Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Company Size
15.3.5.13. Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Countries
15.3.5.14. Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Type of Packaging Container
15.3.5.15. Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Type of Biologic
15.3.5.16. Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Therapeutic Area
15.3.5.17. Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Scale of Operation
15.3.5.18. Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Company Size
15.3.5.19. Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Countries
15.3.5.20. Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Type of Packaging Container
15.3.5.21. Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic
15.3.5.22. Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area
15.3.5.23. Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation
15.3.5.24. Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Company Size
15.3.5.25. Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Countries
15.3.5.26. Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Type of Packaging Container
15.3.5.27. Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic
15.3.5.28. Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area
15.3.5.29. Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation
15.3.5.30. Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Company Size
15.4. Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035
15.4.1. Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Type of Biologic
15.4.2. Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Therapeutic Area
15.4.3. Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Scale of Operation
15.4.4. Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Company Size
15.4.5. Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Geographical Region
15.4.4.1. Biologics Fill Finish Manufacturing Market for Ampoules in North America, 2022-2035: Distribution by Type of Biologic
15.4.4.2. Biologics Fill Finish Manufacturing Market for Ampoules in North America, 2022-2035: Distribution by Therapeutic Area
15.4.4.3. Biologics Fill Finish Manufacturing Market for Ampoules in North America, 2022-2035: Distribution by Scale of Operation
15.4.4.4. Biologics Fill Finish Manufacturing Market for Ampoules in North America, 2022-2035: Distribution by Company Size
15.4.4.5. Biologics Fill Finish Manufacturing Market for Ampoules in Europe, 2022-2035: Distribution by Type of Biologic
15.4.4.6. Biologics Fill Finish Manufacturing Market for Ampoules in Europe, 2022-2035: Distribution by Therapeutic Area
15.4.4.7. Biologics Fill Finish Manufacturing Market for Ampoules in Europe, 2022-2035: Distribution by Scale of Operation
15.4.4.8. Biologics Fill Finish Manufacturing Market for Ampoules in Europe, 2022-2035: Distribution by Company Size
15.4.4.9. Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, 2022-2035: Distribution by Type of Biologic
15.4.4.10. Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, 2022-2035: Distribution by Therapeutic Area
15.4.4.11. Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, 2022-2035: Distribution by Scale of Operation
15.4.4.12. Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, 2022-2035: Distribution by Company Size
15.4.4.13. Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic
15.4.4.14. Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area
15.4.4.15. Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation
15.4.4.16. Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Company Size
15.4.4.17. Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic
15.4.4.18. Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area
15.4.4.19. Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation
15.4.4.20. Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Company Size
15.5. Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035
15.5.1. Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Type of Biologic
15.5.2. Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Therapeutic Area
15.5.3. Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Scale of Operation
15.5.4. Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Company Size
15.5.5. Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Geographical Region
15.5.4.1. Biologics Fill Finish Manufacturing Market for Cartridges in North America, 2022-2035: Distribution by Type of Biologic
15.5.4.2. Biologics Fill Finish Manufacturing Market for Cartridges in North America, 2022-2035: Distribution by Therapeutic Area
15.5.4.3. Biologics Fill Finish Manufacturing Market for Cartridges in North America, 2022-2035: Distribution by Scale of Operation
15.5.4.4. Biologics Fill Finish Manufacturing Market for Cartridges in North America, 2022-2035: Distribution by Company Size
15.5.4.5. Biologics Fill Finish Manufacturing Market for Cartridges in Europe, 2022-2035: Distribution by Type of Biologic
15.5.4.6. Biologics Fill Finish Manufacturing Market for Cartridges in Europe, 2022-2035: Distribution by Therapeutic Area
15.5.4.7. Biologics Fill Finish Manufacturing Market for Cartridges in Europe, 2022-2035: Distribution by Scale of Operation
15.5.4.8. Biologics Fill Finish Manufacturing Market for Cartridges in Europe, 2022-2035: Distribution by Company Size
15.5.4.9. Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, 2022-2035: Distribution by Type of Biologic
15.5.4.10. Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, 2022-2035: Distribution by Therapeutic Area
15.5.4.11. Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, 2022-2035: Distribution by Scale of Operation
15.5.4.12. Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, 2022-2035: Distribution by Company Size
15.5.4.13. Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic
15.5.4.14. Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area
15.5.4.15. Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation
15.5.4.16. Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Company Size
15.5.4.17. Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic
15.5.4.18. Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area
15.5.4.19. Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation
15.5.4.20. Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Company Size
15.6. Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035
15.6.1. Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Type of Biologic
15.6.2. Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Therapeutic Area
15.6.3. Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Scale of Operation
15.6.4. Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Company Size
15.6.5. Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Geographical Region
15.6.4.1. Biologics Fill Finish Manufacturing Market for Syringes in North America, 2022-2035: Distribution by Type of Biologic
15.6.4.2. Biologics Fill Finish Manufacturing Market for Syringes in North America, 2022-2035: Distribution by Therapeutic Area
15.6.4.3. Biologics Fill Finish Manufacturing Market for Syringes in North America, 2022-2035: Distribution by Scale of Operation
15.6.4.4. Biologics Fill Finish Manufacturing Market for Syringes in North America, 2022-2035: Distribution by Company Size
15.6.4.5. Biologics Fill Finish Manufacturing Market for Syringes in Europe, 2022-2035: Distribution by Type of Biologic
15.6.4.6. Biologics Fill Finish Manufacturing Market for Syringes in Europe, 2022-2035: Distribution by Therapeutic Area
15.6.4.7. Biologics Fill Finish Manufacturing Market for Syringes in Europe, 2022-2035: Distribution by Scale of Operation
15.6.4.8. Biologics Fill Finish Manufacturing Market for Syringes in Europe, 2022-2035: Distribution by Company Size
15.6.4.9. Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, 2022-2035: Distribution by Type of Biologic
15.6.4.10. Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, 2022-2035: Distribution by Therapeutic Area
15.6.4.11. Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, 2022-2035: Distribution by Scale of Operation
15.6.4.12. Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, 2022-2035: Distribution by Company Size
15.6.4.13. Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic
15.6.4.14. Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area
15.6.4.15. Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation
15.6.4.16. Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Company Size
15.6.4.17. Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic
15.6.4.18. Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area
15.6.4.19. Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation
15.6.4.20. Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Company Size
15.7. Biologics Fill Finish Manufacturing Market for Vials, 2022-2035
15.7.1. Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Type of Biologic
15.7.2. Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Therapeutic Area
15.7.3. Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Scale of Operation
15.7.4. Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Company Size
15.7.5. Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Geographical Region
15.7.4.1. Biologics Fill Finish Manufacturing Market for Vials in North America, 2022-2035: Distribution by Type of Biologic
15.7.4.2. Biologics Fill Finish Manufacturing Market for Vials in North America, 2022-2035: Distribution by Therapeutic Area
15.7.4.3. Biologics Fill Finish Manufacturing Market for Vials in North America, 2022-2035: Distribution by Scale of Operation
15.7.4.4. Biologics Fill Finish Manufacturing Market for Vials in North America, 2022-2035: Distribution by Company Size
15.7.4.5. Biologics Fill Finish Manufacturing Market for Vials in Europe, 2022-2035: Distribution by Type of Biologic
15.7.4.6. Biologics Fill Finish Manufacturing Market for Vials in Europe, 2022-2035: Distribution by Therapeutic Area
15.7.4.7. Biologics Fill Finish Manufacturing Market for Vials in Europe, 2022-2035: Distribution by Scale of Operation
15.7.4.8. Biologics Fill Finish Manufacturing Market for Vials in Europe, 2022-2035: Distribution by Company Size
15.7.4.9. Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, 2022-2035: Distribution by Type of Biologic 15.7.4.10.
15.7.4.11. Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, 2022-2035: Distribution by Scale of Operation
15.7.4.12. Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, 2022-2035: Distribution by Company Size
15.7.4.13. Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic
15.7.4.14. Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area
15.7.4.15. Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation
15.7.4.16. Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Company Size
15.7.4.17. Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic
15.7.4.18. Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area
15.7.4.19. Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation
15.7.4.20. Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Company Size 

16 FUTURE GROWTH OPPORTUNITIES

16.1. Chapter Overview
16.2. Growing Biopharmaceutical Pipeline
16.3. Increase in Outsourcing of Fill/Finish Activities
16.4. Rising Focus on Self-Administration of Drugs
16.5. Advances in Aseptic Fill/Finish Technologies
16.6. Growing Opportunities in the Asia Pacific Region

 17 CASE STUDY: ROBOTIC SYSTEMS IN FILL/FINISH OPERATIONS

17.1. Chapter Overview
17.2. Contract Service Providers: List of Fill/Finish Equipment
17.3. Role of Robotic Systems in Fill/Finish Operations
17.3.1. Types of Robots Used in Pharmaceutical Operations
17.3.2. Key Considerations for Selecting a Robotic System
17.3.3. Advantages of Robotic Systems
17.3.4. Disadvantages of Robotic Systems
17.4. Companies Providing Robots for Use in the Pharmaceutical Industry
17.5. Companies Providing Isolator-based Aseptic Filling Systems
17.6. Concluding Remarks
 
18 CASE STUDY: READY TO USE PACKAGING COMPONENTS FOR ASEPTIC FILL FINISH

18.1. Chapter Overview
18.2. Role of Ready to Use Packaging Components in Aseptic Fill Finish Operations
18.2.1. Advantages of Ready to Use Packaging Components
18.2.2. Disadvantages of Ready to Use Packaging Components
18.3. Companies Providing Ready to Use Packaging Components
18.4. Conclusion

19 CONCLUDING REMARKS

 20 EXECUTIVE INSIGHTS
20.1 Chapter Overview
20.2 IDT Biologika
20.2.1. Company Snapshot
20.2.1. Interview Transcript: Gregor Kawaletz, Chief Commercial Officer
20.3 Cytovance Biologics
20.3.1. Company Snapshot
20.3.2. Interview Transcript: Matt Delaney, Vice President of Business Development and Marketing
20.4. Syngene
20.4.1. Company Snapshot
20.4.2. Interview Transcript: Purushottam Singnurkar, Research Director and Head of Formulation Development
20.5 oncomed manufacturing
20.5.1. Company Snapshot
20.5.2. Interview Transcript: Ales Sima, Business Development Manager
20.6 Yposkesi
20.6.1. Company Snapshot
20.6.2. Interview Transcript: Amit, Technology Watch Manager

20.7 HALIX

20.7.1. Company Snapshot
20.7.2. Interview Transcript: Jos Vergeest, International Business Developer 

21 APPENDIX 1: TABULATED DATA 

22 APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 3.1 Various Types of Biologics
Figure 3.2 Types of Third-Party Service Providers
Figure 3.3 Commonly Outsourced Operations in the Biopharmaceutical Industry
Figure 3.4 Steps Involved in Fill/Finish of Biologics
Figure 3.5 Key Considerations for Selecting a CMO Partner
Figure 3.6 Risks and Challenges of Outsourcing Biologics Fill / Finish Operations
Figure 4.1 Biologics Fill/Finish Service Providers: Distribution by Year of Establishment
Figure 4.2 Biologics Fill/Finish Service Providers: Distribution by Company Size
Figure 4.3 Biologics Fill / Finish Service Providers: Distribution by Location of Headquarters
Figure 4.4 Biologics Fill/Finish Service Providers: Distribution by Location of Fill/Finish Facilities
Figure 4.5 Biologics Fill/Finish Service Providers: Distribution by Type of Packaging Container(s) Used
Figure 4.6 Biologics Fill/Finish Service Providers: Distribution by Type of Biologic(s) Manufactured and Type of Packaging Container(s) Used
Figure 4.7 Biologics Fill/Finish Service Providers: Distribution by Scale of Operation
Figure 4.8 Biologics Fill/Finish Service Providers: Distribution by Additional Drug Product-related Services Offered
Figure 5.1 Company Competitiveness Analysis: Biologics Fill/Finish Service Providers in North America
Figure 5.2 Company Competitiveness Analysis: Players Offering Services for Ampoules (North America)
Figure 5.3 Company Competitiveness Analysis: Players Offering Services for Cartridges (North America)
Figure 5.4 Company Competitiveness Analysis: Players Offering Services for Syringes (North America)
Figure 5.5 Company Competitiveness Analysis: Players Offering Services for Vials (North America)
Figure 5.6 Company Competitiveness Analysis: Biologics Fill/Finish Service Providers in (Europe)
Figure 5.7 Company Competitiveness Analysis: Players Offering Services for Ampoules (Europe)
Figure 5.8 Company Competitiveness Analysis: Players Offering Services for Cartridges (Europe)
Figure 5.9 Company Competitiveness Analysis: Players Offering Services for Syringes (Europe)
Figure 5.10 Company Competitiveness Analysis: Players Offering Services for Vials (Europe)
Figure 5.11 Company Competitiveness Analysis: Biologics Fill/Finish Service Providers in (Asia Pacific and Rest of the World)
Figure 5.12 Company Competitiveness Analysis: Players Offering Services for Ampoules (Asia Pacific and Rest of the World)
Figure 5.13 Company Competitiveness Analysis: Players Offering Services for Cartridges (Asia Pacific and Rest of World)
Figure 5.14 Company Competitiveness Analysis: Players Offering Services for Syringes (Asia Pacific and Rest of the World)
Figure 5.15 Company Competitiveness Analysis: Players Offering Services for Vials (Asia Pacific and Rest of the World)
Figure 6.1 AbbVie: Annual Revenues, 2017-H1 2022 (USD Billion)
Figure 6.2 Baxter International: Annual Revenues, 2017-H1 2022 (USD Billion)
Figure 6.3 Merck: Annual Revenues, 2017-H1 2022 (EUR Billion)
Figure 6.4 Catalent Biologics: Annual Revenues, FY 2017-FY 2022 (USD Billion)
Figure 6.5 Thermo Fisher Scientific: Annual Revenues, 2017-H1 2022 (USD Billion)
Figure 6.6 Charles River Laboratories: Annual Revenues, 2017-H1 2022 (USD Billion)
Figure 7.1 Boehringer Ingelheim: Annual Revenues, 2017-H1 2022 (EUR Billion)
Figure 7.2 Lonza: Annual Revenues, 2017-H1 2022 (CHF Billion)
Figure 7.3 Pierre Fabre: Annual Revenues, FY 2018-FY 2021 (EUR Billion)
Figure 7.4 Recipharm: Annual Revenues, FY 2017-FY 2020 (SEK Billion)
Figure 7.6 Wacker Chemie: Annual Revenues, 2017-H1 2022 (EUR Billion)
Figure 7.7 Fresenius Kabi: Annual Revenues, 2017-H1 2022 (EUR Billion)
Figure 7.8 Glaxo SmithKline: Annual Revenues, 2017-H1 2022 (GBP Billion)
Figure 8.1 Asymchem: Annual Revenues, 2017-2020 (USD Billion)
Figure 8.2 Samsung Biologics: Annual Revenues, 2017-H1 2022 (KRW Billion)
Figure 8.3 Syngene: Annual Revenues, FY 2017-FY 2022 (INR Million)
Figure 8.4 Takara Bio: Annual Revenues, 2017-H1 2022 (JPY Billion)
Figure 8.5 WuXi Biologics: Annual Revenues, 2017-H1 2022 (RMB Million)
Figure 9.1 Partnerships and Collaborations: Cumulative Trend by Year, 2013-2022
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Scale of Operation
Figure 9.4 Partnerships and Collaborations: Distribution by Type of Service(s) Offered
Figure 9.5 Partnerships and Collaborations: Distribution by Type of Process(es)
Figure 9.6 Partnerships and Collaborations: Distribution by Type of Biologic(s) Involved
Figure 9.7 Most Active Players: Distribution by Number of Partnerships
Figure 9.8 Partnerships and Collaborations: Distribution by Geographical Region
Figure 9.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 10.1 Expansions: Distribution by Year of Expansion, 2013-2022 (till August)
Figure 10.2 Expansions: Distribution by Type of Expansion
Figure 10.3 Expansions: Distribution by Type of Packaging Container(s) Used
Figure 10.4 Expansions: Distribution by Type of Expansion and Type of Service(s) Offered
Figure 10.5 Expansions: Distribution by Type of Biologic(s) Involved
Figure 10.6 Expansions: Distribution by Type of Biologic(s) Involved and Scale of Operation
Figure 10.7 Expansions: Distribution by Geographical Region
Figure 10.8 Expansions: Distribution by Location of Expansion Project
Figure 10.9 Most Active Players: Distribution by Number of Expansions
Figure 10.10 Expansions in North America: Distribution by Type of Service(s) Offered and Type of Biologic(s) Involved
Figure 10.11 Expansions in Europe: Distribution by Type of Service(s) Offered and Type of Biologic(s) Involved
Figure 10.12 Expansions in Asia Pacific and Rest of the World: Distribution by Type of Service(s) Offered and Type of Biologic(s) Involved
Figure 11.1 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Type of Packaging (Million Units)
Figure 11.2 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Company Size (Million Units)
Figure 11.3 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Scale of Operation (Million Units)
Figure 11.4 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Location of Headquarters (Million Units)
Figure 11.5 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Figure 11.6 Global Fill/Finish Capacity (by Fill Volume): Distribution by Type of Packaging (Liters)
Figure 11.7 Global Fill/Finish Capacity (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.8 Global Fill/Finish Capacity (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.9 Global Fill/Finish Capacity (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.10 Global Fill/Finish Capacity (by Fill Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Figure 11.11 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Figure 11.12 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Range of Capacity by Company Size (Thousand Units)
Figure 11.13 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.14 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.15 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Figure 11.16 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.17 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Range of Capacity by Company Size (Liters)
Figure 11.18 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.19 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.20 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Figure 11.21 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Figure 11.22 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Range of Capacity by Company Size (Thousand Units)
Figure 11.23 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.24 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.25 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Figure 11.26 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.27 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Range of Capacity by Company Size (Liters)
Figure 11.28 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.29 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.30 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Figure 11.31 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Range of Capacity by Company Size (Thousand Units)
Figure 11.32 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Range of Capacity by Company Size (Thousand Units)
Figure 11.33 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.34 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.35 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Figure 11.36 Global Fill/Finish Capacity for Syringes (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.37 Global Fill/Finish Capacity for Syringes (by Fill Volume): Range of Capacity by Company Size (Liters)
Figure 11.38 Global Fill/Finish Capacity for Syringes (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.39 Global Fill/Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.40 Global Fill/Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Figure 11.41 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Figure 11.42 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Range of Capacity by Company Size (Thousand Units)
Figure 11.43 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Figure 11.44 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Figure 11.45 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Figure 11.46 Global Fill/Finish Capacity for Vials (by Fill Volume): Distribution by Company Size (Liters)
Figure 11.47 Global Fill/Finish Capacity for Vials (by Fill Volume): Range of Capacity by Company Size (Liters)
Figure 11.48 Global Fill/Finish Capacity for Vials (by Fill Volume): Distribution by Scale of Operation (Liters)
Figure 11.49 Global Fill/Finish Capacity for Vials (by Fill Volume): Distribution by Location of Headquarters (Liters)
Figure 11.50 Global Fill/Finish Capacity for Vials (by Fill Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Figure 12.1 Global Demand for Biologics Fill Finish Manufacturing (Million Liters)
Figure 12.2 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Type of Packaging Container (Liters)
Figure 12.3 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Type of Biologic (Liters)
Figure 12.4 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Therapeutic Area (Liters)
Figure 12.5 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Scale of Operation (Liters)
Figure 12.6 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Company Size (Liters)
Figure 12.7 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Geographical Location (Liters)
Figure 12.8 Global Biologics Fill Finish Manufacturing: Demand and Supply, 2022-2035
Figure 13.1 Biologics Manufacturing and Fill/Finish: Key Performance Indicators (KPIs)
Figure 13.2 Financial Indicators: Comparative Analysis of KPIs Considered by Big Pharma Companies
Figure 13.3 Financial Indicators: Big Pharma Perspective
Figure 13.4 Financial Indicators: Contract Manufacturers’ Perspective
Figure 13.5 Process / Capability-related Indicators: Comparative Analysis of KPIs of Big Pharma Companies
Figure 13.6 Process / Capability-related Indicators: Big Pharma Perspective
Figure 13.7 Process / Capability-related Indicators: Contract Manufacturers’ Perspective
Figure 13.8 Market Reputation-related Indicators: Comparative Analysis of KPIs of Big Pharma Companies
Figure 13.9 Market Reputation-related Indicators: Big Pharma Perspective
Figure 13.10 Market Reputation-related Indicators: Contract Manufacturers’ Perspective
Figure 13.11 Other Performance Indicators: Contract Manufacturers’ Perspective
Figure 14.1 Regional Capability Assessment: Biologic Fill/Finish Capabilities in North America
Figure 14.2 Regional Capability Assessment: Biologic Fill/Finish Capabilities in Europe
Figure 14.3 Regional Capability Assessment: Biologic Fill/Finish Capabilities in Asia Pacific and Rest of the World
Figure 14.4 Regional Capability Analysis: Biologic Fill/Finish Installed Capacity in Different Geographical Regions
Figure 14.4 Regional Capability Assessment: Comparison of Capabilities across Different Regions
Figure 15.1 Overall Biologics Fill Finish Manufacturing Market, 2022-2035 (USD Billion)
Figure 15.2 Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Figure 15.3 Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.4 Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.5 Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.6 Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.7 Biologics Fill Finish Manufacturing Market, 2022-2035: Distribution by Geographical Region (USD Million)
Figure 15.8 Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Countries (USD Million)
Figure 15.9 Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 1510 Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Figure 15.11 Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.12 Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.13 Biologics Fill Finish Manufacturing Market in North America, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.14 Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Countries (USD Million)
Figure 15.15 Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Figure 15.16 Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.17 Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Therapeutic Are (USD Million)
Figure 15.18 Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.19 Biologics Fill Finish Manufacturing Market in Europe, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.20 Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Countries (USD Million)
Figure 15.21 Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Figure 15.22 Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.23 Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.24 Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.25 Biologics Fill Finish Manufacturing Market in Asia Pacific, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.26 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Countries (USD Million)
Figure 15.27 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Figure 15.28 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.29 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.30 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.31 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.32 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Countries (USD Million)
Figure 15.33 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Figure 15.34 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.35 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.36 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.37 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.38 Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035 (USD Million)
Figure 15.39 Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.40 Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.41 Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.42 Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.43 Biologics Fill Finish Manufacturing Market for Ampoules, 2022-2035: Distribution by Geographical Region (USD Million)
Figure 15.44 Biologics Fill Finish Manufacturing Market for Ampoules in North America, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.45 Biologics Fill Finish Manufacturing Market for Ampoules in North America, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.46 Biologics Fill Finish Manufacturing Market for Ampoules in North America, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.47 Biologics Fill Finish Manufacturing Market for Ampoules in North America, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.48 Biologics Fill Finish Manufacturing Market for Ampoules in Europe, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.49 Biologics Fill Finish Manufacturing Market for Ampoules in Europe, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.50 Biologics Fill Finish Manufacturing Market for Ampoules in Europe, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.51 Biologics Fill Finish Manufacturing Market for Ampoules in Europe, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.52 Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.53 Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.54 Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.55 Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.56 Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.57 Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.58 Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.59 Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.60 Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.61 Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.62 Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.63 Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.64 Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035(USD Million)
Figure 15.65 Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.66 Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.67 Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.68 Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.69 Biologics Fill Finish Manufacturing Market for Cartridges, 2022-2035: Distribution by Geographical Region (USD Million)
Figure 15.70 Biologics Fill Finish Manufacturing Market for Cartridges in North America, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.71 Biologics Fill Finish Manufacturing Market for Cartridges in North America, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.72 Biologics Fill Finish Manufacturing Market for Cartridges in North America, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.73 Biologics Fill Finish Manufacturing Market for Cartridges in North America, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.74 Biologics Fill Finish Manufacturing Market for Cartridges in Europe, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.75 Biologics Fill Finish Manufacturing Market for Cartridges in Europe, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.76 Biologics Fill Finish Manufacturing Market for Cartridges in Europe, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.77 Biologics Fill Finish Manufacturing Market for Cartridges in Europe, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.78 Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.79 Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.80 Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.81 Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.82 Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.83 Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.84 Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.85 Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.86 Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.87 Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.88 Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.89 Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.90 Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035 (USD Million)
Figure 15.91 Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.92 Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.93 Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.94 Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.95 Biologics Fill Finish Manufacturing Market for Syringes, 2022-2035: Distribution by Geographical Region (USD Million)
Figure 15.96 Biologics Fill Finish Manufacturing Market for Syringes in North America, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.97 Biologics Fill Finish Manufacturing Market for Syringes in North America, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.98 Biologics Fill Finish Manufacturing Market for Syringes in North America, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.99 Biologics Fill Finish Manufacturing Market for Syringes in North America, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.100 Biologics Fill Finish Manufacturing Market for Syringes in Europe, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.101 Biologics Fill Finish Manufacturing Market for Syringes in Europe, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.102 Biologics Fill Finish Manufacturing Market for Syringes in Europe, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.103 Biologics Fill Finish Manufacturing Market for Syringes in Europe, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.104 Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.105 Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.106 Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.107 Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.108 Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.109 Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.110 Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.111 Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.112 Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.113 Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.114 Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.115 Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.116 Biologics Fill Finish Manufacturing Market for Vials, 2022-2035(USD Million)
Figure 15.117 Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.118 Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.119 Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.120 Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.121 Biologics Fill Finish Manufacturing Market for Vials, 2022-2035: Distribution by Geographical Region (USD Million)
Figure 15.122 Biologics Fill Finish Manufacturing Market for Vials in North America, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.123 Biologics Fill Finish Manufacturing Market for Vials in North America, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.124 Biologics Fill Finish Manufacturing Market for Vials in North America, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.125 Biologics Fill Finish Manufacturing Market for Vials in North America, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.126 Biologics Fill Finish Manufacturing Market for Vials in Europe, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.127 Biologics Fill Finish Manufacturing Market for Vials in Europe, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.128 Biologics Fill Finish Manufacturing Market for Vials in Europe, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.129 Biologics Fill Finish Manufacturing Market for Vials in Europe, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.130 Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.131 Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.132 Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.133 Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.134 Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.135 Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.136 Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.137 Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, 2022-2035: Distribution by Company Size (USD Million)
Figure 15.138 Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Type of Biologic (USD Million)
Figure 15.139 Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Therapeutic Area (USD Million)
Figure 15.140 Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Scale of Operation (USD Million)
Figure 15.141 Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, 2022-2035: Distribution by Company Size (USD Million)
Figure 16.1 Growth Opportunities for Biologics Fill/Finish Service Providers
Figure 16.2 Drug Products Approved by the FDA, 2011-2021
Figure 17.1 Key Considerations for Selecting a Robotic System
Figure 17.2 Advantages of Robotic Systems in Pharmaceutical Operations
Figure 18.1 Key Drivers of Ready-to-Use Platform
Figure 19.1 Concluding Remarks: Current Biologic Fill/Finish Service Providers Market Landscape Summary
Figure 19.2 Concluding Remarks: Recent Partnerships
Figure 19.3 Concluding Remarks: Recent Expansions
Figure 19.4 Concluding Remarks: Capacity Analysis
Figure 19.5 Concluding Remarks: Demand Analysis
Figure 19.6 Concluding Remarks: Market Sizing and Opportunity Analysis for Biologic Fill Finish Manufacturing Market  

List Of Tables

Table 3.1 Best-Selling Drugs of 2022
Table 4.1 Biologics Fill/Finish Service Providers: List of Companies
Table 4.2 Biologics Fill/Finish Service Providers: Information on Type of Packaging Container(s) Used
Table 4.3 Biologics Fill/Finish Service Providers: Information on Type of Biologic(s) Manufactured
Table 4.4 Biologics Fill/Finish Service Providers: Information on Scale of Operation
Table 4.5 Biologics Fill/Finish Service Providers: Information on Additional Drug Product-related Services Offered
Table 4.6 Biologics Fill/Finish Service Providers: Information on Fill/Finish Capacity
Table 6.1 Biologics Fill/Finish Service Providers in North America: List of Profiled Companies
Table 6.2 AbbVie Contract Manufacturing: Company Overview
Table 6.3 AbbVie Contract Manufacturing: Overview of Service Portfolio
Table 6.4 AbbVie Contract Manufacturing: Overview of Fill Finish Manufacturing
Table 6.5 AbbVie Contract Manufacturing: Sterile Manufacturing Facilities
Table 6.6 AbbVie Contract Manufacturing: Recent Developments and Future Outlook
Table 6.7 BioPharma Solutions: Company Overview
Table 6.8 BioPharma Solutions: Overview of Service Portfolio
Table 6.9 BioPharma Solutions: Overview of Fill Finish Manufacturing
Table 6.8 BioPharma Solutions: Sterile Manufacturing Facilities
Table 6.10 BioPharma Solutions: Recent Developments and Future Outlook
Table 6.11 BioReliance: Company Overview
Table 6.12 BioReliance: Overview of Service Portfolio
Table 6.13 BioReliance: Overview of Fill Finish Manufacturing
Table 6.14 BioReliance: Sterile Manufacturing Facilities
Table 6.15 BioReliance: Recent Developments and Future Outlook
Table 6.16 Catalent Biologics: Company Overview
Table 6.17 Catalent Biologics: Overview of Service Portfolio
Table 6.18 Catalent Biologics: Overview of Fill Finish Manufacturing
Table 6.19 Catalent Biologics: Sterile Manufacturing Facilities
Table 6.20 Catalent Biologics: Recent Developments and Future Outlook
Table 6.21 Patheon: Company Overview
Table 6.22 Patheon: Overview of Service Portfolio
Table 6.23 Patheon: Overview of Fill Finish Manufacturing
Table 6.24 Patheon: Sterile Manufacturing Facilities
Table 6.25 Patheon: Recent Developments and Future Outlook
Table 6.26 Charles River Laboratories: Company Snapshot
Table 6.27 Charles River Laboratories: Overview of Fill Finish Manufacturing
Table 6.28 Charles River Laboratories: Recent Developments and Future Outlook
Table 7.1 Biologics Fill/Finish Service Providers in Europe: List of Profiled Companies
Table 7.2 Boehringer Ingelheim BioXcellence: Company Overview
Table 7.3 Boehringer Ingelheim BioXcellence: Overview of Service Portfolio
Table 7.4 Boehringer Ingelheim BioXcellence: Overview of Fill Finish Manufacturing
Table 7.5 Boehringer Ingelheim BioXcellence: Sterile Manufacturing Facilities
Table 7.6 Boehringer Ingelheim BioXcellence: Recent Developments and Future Outlook
Table 7.7 Lonza: Company Overview
Table 7.8 Lonza: Overview of Service Portfolio
Table 7.9 Lonza: Overview of Fill Finish Manufacturing
Table 7.10 Lonza: Sterile Manufacturing Facilities
Table 7.11 Lonza: Recent Developments and Future Outlook
Table 7.12 Pierre Fabre: Company Overview
Table 7.13 Pierre Fabre: Overview of Service Portfolio
Table 7.14 Pierre Fabre: Overview of Fill Finish Manufacturing
Table 7.15 Pierre Fabre: Sterile Manufacturing Facilities
Table 7.16 Pierre Fabre: Recent Developments and Future Outlook
Table 7.17 Recipharm: Company Overview
Table 7.18 Recipharm: Overview of Service Portfolio
Table 7.19 Recipharm: Overview of Fill Finish Manufacturing
Table 7.20 Recipharm: Sterile Manufacturing Facilities
Table 7.21 Recipharm: Recent Developments and Future Outlook
Table 7.22 Wacker Biotech: Company Overview
Table 7.23 Wacker Biotech: Overview of Service Portfolio
Table 7.24 Wacker Biotech: Overview of Fill/Finish Related Services
Table 7.25 Wacker Biotech: Sterile Manufacturing Facilities
Table 7.26 Wacker Biotech: Recent Developments and Future Outlook
Table 7.27 Fareva: Company Overview
Table 7.28 Fareva: Overview of Fill Finish Manufacturing
Table 7.29 Fareva: Recent Developments and Future Outlook
Table 7.30 Fresenius Kabi: Company Overview
Table 7.31 Fresenius Kabi: Overview of Fill Finish Manufacturing
Table 7.32 Glaxo SmithKline: Company Overview
Table 7.33 Glaxo SmithKline: Overview of Fill Finish Manufacturing
Table 7.34 Glaxo SmithKline: Recent Developments and Future Outlook
Table 8.1 Biologics Fill/Finish Service Providers in Asia Pacific: List of Profiled Companies
Table 8.2 Asymchem: Company Overview
Table 8.3 Asymchem: Overview of Service Portfolio
Table 8.4 Asymchem: Overview of Fill Finish Manufacturing
Table 8.5 Asymchem: Sterile Manufacturing Facilities
Table 8.6 Asymchem: Recent Developments and Future Outlook
Table 8.7 Samsung Biologics: Company Overview
Table 8.8 Samsung Biologics: Overview of Service Portfolio
Table 8.9 Samsung Biologics: Overview of Fill Finish Manufacturing
Table 8.10 Samsung Biologics: Recent Developments and Future Outlook
Table 8.11 Syngene: Company Overview
Table 8.12 Syngene: Overview of Service Portfolio
Table 8.13 Syngene: Overview of Fill Finish Manufacturing
Table 8.14 Syngene: Recent Developments and Future Outlook
Table 8.15 Takara Bio: Company Overview
Table 8.16 Takara Bio: Overview of Service Portfolio
Table 8.17 Takara Bio: Overview of Fill Finish Manufacturing
Table 8.18 Takara Bio: Recent Developments and Future Outlook
Table 8.19 WuXi Biologics: Company Overview
Table 8.20 WuXi Biologics: Overview of Services Portfolio
Table 8.21 Wuxi Biologics: Overview of Fill Finish Manufacturing
Table 8.22 WuXi Biologics: Sterile Manufacturing Facilities
Table 8.23 WuXi Biologics: Recent Developments and Future Outlook
Table 8.24 Hetero Drugs: Company Overview
Table 8.25 Hetero Drugs: Overview of Fill Finish Manufacturing
Table 8.26 Intas Pharmaceuticals: Company Overview
Table 8.27 Intas Pharmaceuticals: Overview of Fill Finish Manufacturing
Table 9.1 Biologics Fill/Finish Service Providers: Partnerships and Collaborations, 2013-2022
Table 9.2 Partnerships and Collaborations: Information on Type of Service(s) Offered, 2013-2022
Table 9.3 Partnerships and Collaborations: Information on Type of Biologic(s) Involved, 2013-2022
Table 10.1 Biologics Fill/Finish Service Providers: Recent Expansions, 2013-2022
Table 10.2 Expansions, 2013-2022: Information on Type of Packaging Container(s) Used
Table 10.3 Recent Expansions, 2013-2022: Information on Type of Service(s) Offered
Table 10.4 Expansions, 2013-2022: Information on Type of Biologic(s) Involved
Table 11.1 Average Fill/Finish Capacity for Ampoules (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.2 Average Fill/Finish Capacity for Cartridges (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.3 Average Fill/Finish Capacity for Syringes (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.4 Average Fill/Finish Capacity for Vials (Number of Units Filled) by Company Size (Sample Data Set)
Table 11.5 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Company Size
Table 11.6 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Distribution by Company Size
Table 11.7 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Company Size
Table 11.8 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Distribution by Company Size
Table 11.9 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Distribution by Company Size
Table 11.10 Global Fill/Finish Capacity for Syringes (by Fill Volume): Distribution by Company Size
Table 11.11 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Distribution by Company Size
Table 11.12 Global Fill/Finish Capacity for Vials (by Fill Volume): Distribution by Company Size
Table 12.1 Biologics Fill/Finish Outsourcing: Annual Supply, 2022-2035 (Million Liters)
Table 16.1 Patent Expiry of Biologics, 2021-2023
Table 17.1 Biologics Fill/Finish Service Providers: Information on Fill/Finish Equipment
Table 17.2 List of Pharmaceutical Robotics Manufacturers
Table 17.3 Isolator based Aseptic Filling Systems: Information on Compatible Primary Container
Table 18.1 List of Companies Supplying Ready-to-Use Packaging Components
Table 19.1 Biologics Fill/Finish Service Providers: Summary of the Report
Table 21.1 Biologics Fill/Finish Service Providers: Distribution by Year of Establishment
Table 21.2 Biologics Fill/Finish Service Providers: Distribution by Company Size
Table 21.3 Biologics Fill/Finish Service Providers: Distribution by Location of Headquarters
Table 21.4 Biologics Fill/Finish Service Providers: Distribution by Location of Fill/Finish Facilities
Table 21.5 Biologics Fill/Finish Service Providers: Distribution by Type of Packaging Container(s) Used
Table 21.6 Biologics Fill/Finish Service Providers: Distribution by Type of Biologic(s) Manufactured and Type of Packaging Container(s) Used
Table 21.7 Biologics Fill/Finish Service Providers: Distribution by Scale of Operation
Table 21.8 Biologics Fill/Finish Service Providers: Distribution by Type of Additional Drug Product-related Services Offered
Table 21.9 AbbVie: Annual Revenues, 2017-H1 2022 (USD Billion)
Table 21.10 Baxter International: Annual Revenues, 2017-H1 2022 (USD Billion)
Table 21.11 Merck: Annual Revenues, 2017-H1 2022 (EUR Billion)
Table 21.12 Catalent Biologics: Annual Revenues, FY 2017-FY 2022 (USD Billion)
Table 21.13 Thermo Fisher Scientific: Annual Revenues, 2017-H1 2022 (USD Billion)
Table 21.14 Charles River Laboratories: Annual Revenues, 2017-H1 2022 (USD Billion)
Table 21.15 Boehringer Ingelheim: Annual Revenues, 2017-H1 2022 (EUR Billion)
Table 21.16 Lonza: Annual Revenues, 2017-H1 2022 (CHF Billion)
Table 21.17 Pierre Fabre: Annual Revenues, FY 2018-FY 2021 (EUR Billion)
Table 21.18 Recipharm: Annual Revenues, FY 2017-FY 2020 (SEK Billion)
Table 21.19 Wacker Chemie: Annual Revenues, 2017-H1 2022 (EUR Billion)
Table 21.20 Fresenius Kabi: Annual Revenues, 2017-H1 2022 (EUR Billion)
Table 21.21 Glaxo SmithKline: Annual Revenues, 2017-H1 2022 (GBP Billion)
Table 21.22 Asymchem: Annual Revenues, FY 2017-FY 2020 (USD Billion)
Table 21.23 Samsung Biologics: Annual Revenues, 2017-H1 2022 (KRW Billion)
Table 21.24 Syngene: Annual Revenues, 2017-2022 (INR Million)
Table 21.25 Takara Bio: Annual Revenues, 2017-H1 2022 (JPY Billion)
Table 21.26 WuXi Biologics: Annual Revenues, 2017-H1 2022 (RMB Million)
Table 21.27 Partnerships and Collaborations: Cumulative Year-wise Trend, 2013-2022
Table 21.28 Partnerships and Collaborations: Distribution by Type of Partnership
Table 21.29 Partnerships and Collaborations: Distribution by Scale of Operation
Table 21.30 Partnerships and Collaborations: Distribution by Type of Service(s) Offered
Table 21.31 Partnerships and Collaborations: Distribution by Type of Process(es)
Table 21.32 Partnerships and Collaborations: Distribution by Types of Biologic(s) Involved
Table 21.33 Most Active Players: Distribution by Number of Partnerships
Table 21.34 Partnerships and Collaborations: Distribution by Geographical Region
Table 21.35 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 21.36 Expansions: Distribution by Year of Expansion, 2013-2022
Table 21.37 Expansions: Distribution by Type of Expansion
Table 21.38 Expansions: Distribution by Type of Packaging Container(s) Used
Table 21.39 Expansions: Distribution by Type of Expansion and Type of Service(s) Offered
Table 21.40 Expansions: Distribution by Type of Biologic(s) Involved
Table 21.41 Expansions: Distribution by Type of Biologic and Scale of Operation
Table 21.42 Expansions: Distribution by Geographical Location
Table 21.43 Expansions: Distribution by Location of Expansion Project
Table 21.44 Most Active Players: Distribution by Number of Expansions
Table 21.45 Expansions in North America: Distribution by Type of Service(s) Offered and Type of Biologic(s) Involved
Table 21.46 Expansions in Europe: Distribution by Type of Service(s) Offered and Type of Biologic(s) Involved
Table 21.47 Expansions in Asia Pacific: Distribution by Type of Service(s) Offered and Type of Biologic(s) Involved
Table 21.48 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Type of Packaging (Million Units)
Table 21.49 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Company Size (Million Units)
Table 21.50 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Scale of Operation (Million Units)
Table 21.51 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Location of Headquarters (Million Units)
Table 21.52 Global Fill/Finish Capacity (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Table 21.53 Global Fill/Finish Capacity (by Fill Volume): Distribution by Type of Packaging (Kilo Liters)
Table 21.54 Global Fill/Finish Capacity (by Fill Volume): Distribution by Company Size (Kilo Liters)
Table 21.55 Global Fill/Finish Capacity (by Fill Volume): Distribution by Scale of Operation (Kilo Liters)
Table 21.56 Global Fill/Finish Capacity (by Fill Volume): Distribution by Location of Headquarters (Kilo Liters)
Table 21.57 Global Fill/Finish Capacity (by Fill Volume): Distribution by Location of Fill /
Table 21.58 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Table 21.59 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.60 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.61 Global Fill/Finish Capacity for Ampoules (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Table 21.62 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Distribution by Company Size (Liters)
Table 21.63 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.64 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.65 Global Fill/Finish Capacity for Ampoules (by Fill Volume): Distribution byLocation of Fill/Finish Facilities (Liters)
Table 21.66 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Table 21.67 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.68 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.69 Global Fill/Finish Capacity for Cartridges (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Table 21.70 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Distribution by Company Size (Liters)
Table 21.71 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.72 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.73 Global Fill/Finish Capacity for Cartridges (by Fill Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Table 21.74 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Distribution by Company Size
Table 21.75 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.76 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.77 Global Fill/Finish Capacity for Syringes (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Table 21.78 Global Fill/Finish Capacity for Syringes (by Fill Volume): Distribution by Company Size (Liters)
Table 21.79 Global Fill/Finish Capacity for Syringes (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.80 Global Fill/Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.81 Global Fill/Finish Capacity for Syringes (by Fill Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Table 21.82 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Distribution by Company Size (Thousand Units)
Table 21.83 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Distribution by Scale of Operation (Thousand Units)
Table 21.84 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Headquarters (Thousand Units)
Table 21.85 Global Fill/Finish Capacity for Vials (by Number of Units Filled): Distribution by Location of Fill/Finish Facilities (Thousand Units)
Table 21.86 Global Fill/Finish Capacity for Vials (by Fill Volume): Distribution by Company Size (Liters)
Table 21.87 Global Fill/Finish Capacity for Vials (by Fill Volume): Distribution by Scale of Operation (Liters)
Table 21.88 Global Fill/Finish Capacity for Vials (by Fill Volume): Distribution by Location of Headquarters (Liters)
Table 21.89 Global Fill/Finish Capacity for Vials (by Fill Volume): Distribution by Location of Fill/Finish Facilities (Liters)
Table 21.90 Global Demand for Biologics Fill Finish Manufacturing (Million Liters)
Table 21.91 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Type of Packaging Container (Kilo Liters)
Table 21.92 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Type of Biologic (Kilo Liters)
Table 21.93 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Therapeutic Area (Kilo Liters)
Table 21.94 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Scale of Operation (Kilo Liters)
Table 21.95 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Company Size (Kilo Liters)
Table 21.96 Global Demand for Biologics Fill Finish Manufacturing: Distribution by Geographical Location (Kilo Liters)
Table 21.97 Global Biologics Fill Finish Manufacturing: Demand and Supply, 2022-2035
Table 21.98 Overall Biologics Fill Finish Manufacturing Market, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Billion)
Table 21.99 Biologics Fill Finish Manufacturing Market, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Table 21.100 Biologics Fill Finish Manufacturing Market, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.101 Biologics Fill Finish Manufacturing Market, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.102 Biologics Fill Finish Manufacturing Market, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.103 Biologics Fill Finish Manufacturing Market, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.104 Biologics Fill Finish Manufacturing Market, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Geographical Region (USD Million)
Table 21.105 Biologics Fill Finish Manufacturing Market in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Countries (USD Million)
Table 21.106 Biologics Fill Finish Manufacturing Market in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Table 21.107 Biologics Fill Finish Manufacturing Market in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.108 Biologics Fill Finish Manufacturing Market in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.109 Biologics Fill Finish Manufacturing Market in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.110 Biologics Fill Finish Manufacturing Market in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.111 Biologics Fill Finish Manufacturing Market in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Countries (USD Million)
Table 21.112 Biologics Fill Finish Manufacturing Market in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Table 21.113 Biologics Fill Finish Manufacturing Market in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.114 Biologics Fill Finish Manufacturing Market in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.115 Biologics Fill Finish Manufacturing Market in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.116 Biologics Fill Finish Manufacturing Market in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.117 Biologics Fill Finish Manufacturing Market in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Countries (USD Million)
Table 21.118 Biologics Fill Finish Manufacturing Market in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Table 21.119 Biologics Fill Finish Manufacturing Market in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.120 Biologics Fill Finish Manufacturing Market in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.121 Biologics Fill Finish Manufacturing Market in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.122 Biologics Fill Finish Manufacturing Market in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.123 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Countries (USD Million)
Table 21.124 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Table 21.125 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.126 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.127 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.128 Biologics Fill Finish Manufacturing Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.129 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Countries (USD Million)
Table 21.130 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Packaging Container (USD Million)
Table 21.131 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.132 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.133 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.134 Biologics Fill Finish Manufacturing Market in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.135 Biologics Fill Finish Manufacturing Market for Ampoules, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 21.136 Biologics Fill Finish Manufacturing Market for Ampoules, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.137 Biologics Fill Finish Manufacturing Market for Ampoules, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.138 Biologics Fill Finish Manufacturing Market for Ampoules, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.139 Biologics Fill Finish Manufacturing Market for Ampoules, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.140 Biologics Fill Finish Manufacturing Market for Ampoules, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Geographical Region (USD Million)
Table 21.141 Biologics Fill Finish Manufacturing Market for Ampoules in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.142 Biologics Fill Finish Manufacturing Market for Ampoules in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.143 Biologics Fill Finish Manufacturing Market for Ampoules in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale pf Operation (USD Million)
Table 21.144 Biologics Fill Finish Manufacturing Market for Ampoules in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.145 Biologics Fill Finish Manufacturing Market for Ampoules in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.146 Biologics Fill Finish Manufacturing Market for Ampoules in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.147 Biologics Fill Finish Manufacturing Market for Ampoules in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.148 Biologics Fill Finish Manufacturing Market for Ampoules in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.149 Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.150 Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.151 Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.152 Biologics Fill Finish Manufacturing Market for Ampoules in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.153 Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.154 Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.155 Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.156 Biologics Fill Finish Manufacturing Market for Ampoules in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.157 Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.158 Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.159 Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.160 Biologics Fill Finish Manufacturing Market for Ampoules in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.161 Biologics Fill Finish Manufacturing Market for Cartridges, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 21.162 Biologics Fill Finish Manufacturing Market for Cartridges, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.163 Biologics Fill Finish Manufacturing Market for Cartridges, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.164 Biologics Fill Finish Manufacturing Market for Cartridges, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.165 Biologics Fill Finish Manufacturing Market for Cartridges, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.166 Biologics Fill Finish Manufacturing Market for Cartridges, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Geographical Region (USD Million)
Table 21.167 Biologics Fill Finish Manufacturing Market for Cartridges in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.168 Biologics Fill Finish Manufacturing Market for Cartridges in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.169 Biologics Fill Finish Manufacturing Market for Cartridges in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.170 Biologics Fill Finish Manufacturing Market for Cartridges in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.171 Biologics Fill Finish Manufacturing Market for Cartridges in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.172 Biologics Fill Finish Manufacturing Market for Cartridges in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.173 Biologics Fill Finish Manufacturing Market for Cartridges in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.174 Biologics Fill Finish Manufacturing Market for Cartridges in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.175 Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.176 Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.177 Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.178 Biologics Fill Finish Manufacturing Market for Cartridges in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.179 Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.180 Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.181 Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.182 Biologics Fill Finish Manufacturing Market for Cartridges in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.183 Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.184 Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.185 Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.186 Biologics Fill Finish Manufacturing Market for Cartridges in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.187 Biologics Fill Finish Manufacturing Market for Syringes, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 21.188 Biologics Fill Finish Manufacturing Market for Syringes, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.189 Biologics Fill Finish Manufacturing Market for Syringes, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.190 Biologics Fill Finish Manufacturing Market for Syringes, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.191 Biologics Fill Finish Manufacturing Market for Syringes, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.192 Biologics Fill Finish Manufacturing Market for Syringes, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Geographical Region (USD Million)
Table 21.193 Biologics Fill Finish Manufacturing Market for Syringes in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.194 Biologics Fill Finish Manufacturing Market for Syringes in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.195 Biologics Fill Finish Manufacturing Market for Syringes in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.196 Biologics Fill Finish Manufacturing Market for Syringes in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.197 Biologics Fill Finish Manufacturing Market for Syringes in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.198 Biologics Fill Finish Manufacturing Market for Syringes in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.199 Biologics Fill Finish Manufacturing Market for Syringes in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.200 Biologics Fill Finish Manufacturing Market for Syringes in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.201 Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.202 Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.203 Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.204 Biologics Fill Finish Manufacturing Market for Syringes in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.205 Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.206 Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.207 Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.208 Biologics Fill Finish Manufacturing Market for Syringes in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.209 Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.210 Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.211 Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.212 Biologics Fill Finish Manufacturing Market for Syringes in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.213 Biologics Fill Finish Manufacturing Market for Vials, Conservative, Base and Optimistic Scenario, 2022-2035 (USD Million)
Table 21.214 Biologics Fill Finish Manufacturing Market for Vials, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.215 Biologics Fill Finish Manufacturing Market for Vials, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.216 Biologics Fill Finish Manufacturing Market for Vials, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.217 Biologics Fill Finish Manufacturing Market for Vials, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.218 Biologics Fill Finish Manufacturing Market for Vials, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Geographical Region (USD Million)
Table 21.219 Biologics Fill Finish Manufacturing Market for Vials in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.220 Biologics Fill Finish Manufacturing Market for Vials in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.221 Biologics Fill Finish Manufacturing Market for Vials in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.222 Biologics Fill Finish Manufacturing Market for Vials in North America, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.223 Biologics Fill Finish Manufacturing Market for Vials in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.224 Biologics Fill Finish Manufacturing Market for Vials in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.225 Biologics Fill Finish Manufacturing Market for Vials in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.226 Biologics Fill Finish Manufacturing Market for Vials in Europe, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.227 Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.228 Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.229 Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.230 Biologics Fill Finish Manufacturing Market for Vials in Asia Pacific, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.231 Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.232 Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.233 Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.234 Biologics Fill Finish Manufacturing Market for Vials in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.235 Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Type of Biologic (USD Million)
Table 21.236 Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Therapeutic Area (USD Million)
Table 21.237 Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Scale of Operation (USD Million)
Table 21.238 Biologics Fill Finish Manufacturing Market for Vials in Latin America and Rest of the World, Conservative, Base and Optimistic Scenario, 2022-2035: Distribution by Company Size (USD Million)
Table 21.239 Drug Product Pipeline Approved by the FDA, 2011-2021

List Of Companies

The following companies and organizations have been mentioned in the report:

  1. 3P Biopharmaceuticals
  2. Aalto Scientific
  3. ABB
  4. AbbVie
  5. AbbVie Contract Manufacturing
  6. AbTis
  7. Abzena
  8. ACG
  9. ACIC Pharmaceutical Machinery
  10. AdaptVac
  11. ADC Biotechnology
  12. Adimmune 
  13. Advanced BioScience Laboratories
  14. Aenova
  15. Affinity Life Sciences
  16. Afton Scientific
  17. Agilis Biotherapeutics
  18. AJ Biologics
  19. Ajinomoto Bio-Pharma Services
  20. Akron Biotech
  21. AKSO
  22. Akums Drugs and Pharmaceuticals
  23. Alanza
  24. Alcami
  25. Alcon
  26. Aldevron
  27. Alkermes
  28. Althea
  29. Amatsigroup
  30. Ambica Pharma Machines
  31. Amgen
  32. Amicus Therapeutics 
  33. AMRI
  34. Anchiano Therapeutics (formerly known as BioCanCell)
  35. Anchor Mark
  36. Anthos Therapeutics
  37. apceth Biopharma
  38. APG Europe
  39. Aptar Pharma
  40. Aptuit
  41. Arabio
  42. ARaymond Life
  43. Arch Biopartners
  44. Argonaut Manufacturing Services
  45. ARISTO
  46. Ascendia Pharmaceuticals
  47. Aseptic Technologies
  48. Asklepios BioPharmaceutical
  49. AST
  50. AstraZeneca
  51. Asymchem
  52. Ausia BioTech
  53. Austrianova
  54. Automated Systems of Tacoma
  55. Avid Bioservices
  56. Avrio Biopharmaceuticals
  57. AWS Bio-Pharma Technologies
  58. Axcellerate Pharma
  59. B. Braun’s OEM Division
  60. Baccinex
  61. Bausch & Ströbel
  62. BAUSCH Advanced Technology Group (BATG)
  63. Baxter BioPharma Solutions
  64. Bayer
  65. Berkshire Sterile Manufacturing
  66. Binex
  67. Bio Elpida
  68. Bio-Concept Laboratories
  69. BioConnection
  70. Biofabri 
  71. Biogen
  72. BioMARC
  73. Biomay
  74. Biomedical Advanced Research and Development Authority (BARDA)
  75. BioNTech 
  76. BioPharma Solutions
  77. BioReliance
  78. BioSkryb
  79. BioTechLogic
  80. BioTechniques
  81. Biovian
  82. BirgiMefar
  83. Boehringer Ingelheim BioXcellence
  84. Bolt Biotherapeutics
  85. Boston Children’s Hospital
  86. Bristol-Myers Squibb
  87. Bryllan
  88. BSP Pharmaceuticals
  89. Burrard Pharmaceuticals
  90. Bushu Pharmaceuticals
  91. Cangene Corporation
  92. Canton Biologics
  93. CARBOGEN AMCIS
  94. Catalent Biologics
  95. Celgene
  96. Cell Culture Company 
  97. Cellin Technologies
  98. Celonic
  99. Celsee
  100. Cenexi
  101. Cerbios-Pharma
  102. Cerium Pharmaceuticals
  103. ChemPartner
  104. Chime Biologics
  105. China Gateway Biologics
  106. CinnaGen
  107. Citryll
  108. CMAB Biopharma
  109. CMC Biologics
  110. CMIC CMO
  111. Coalition for the Promotion of Innovations for Epidemic Preparedness (CEPI)
  112. Cobra Biologics
  113. Cognate BioServices
  114. Cognitus Consulting
  115. Coldstream Laboratories
  116. Colorado State University
  117. Columbus Venture Partners
  118. Comecer
  119. Cook Pharmica
  120. CordenPharma
  121. Creative Biolabs
  122. Crystal Pharma
  123. CureVac
  124. CytoDyn
  125. Cytovance Biologics
  126. Daikyo Seiko
  127. Dalton Pharma Services
  128. Dara Pharma
  129. Datwyler Sealing Solutions
  130. DENSO 
  131. Dhruv Life Sciences
  132. Disposable Lab
  133. DM Bio
  134. Drugs for Neglected Disease Initiative (DNDi)
  135. DSM Pharmaceutical Products
  136. DWK Life Sciences
  137. EirGen Pharma
  138. EirGenix
  139. Eli Lilly
  140. EMA Pharmaceuticals
  141. Emcure Pharmaceuticals
  142. Emergent BioSolutions
  143. Esco Aster
  144. Etinpro
  145. EuBiologics
  146. EUCODIS Bioscience
  147. Eurofins BioPharma Product Testing Netherlands
  148. Eurofins Scientific
  149. EVER Pharma
  150. ExCellThera
  151. Exelead
  152. Experic
  153. Extract Technology
  154. FANUC America
  155. Fareva
  156. FinVector 
  157. Formosa Laboratories
  158. Fresenius Kabi Contract Manufacturing
  159. Früh Verpackungstechnik
  160. FUJIFILM Diosynth Biotechnologies
  161. GC Pharma
  162. GEA
  163. Genentech
  164. GeneQuantum Healthcare
  165. Generic Specialities
  166. GenIbet Biopharmaceuticals
  167. Genovior Biotech 
  168. Genprex
  169. Gerresheimer
  170. Getinge
  171. GigaGen
  172. Gilead
  173. GlaxoSmithKline 
  174. GLyPharma 
  175. Goodwin Biotechnology
  176. GP Pharm
  177. Grand River Aseptic Manufacturing
  178. Groninger
  179. GTCR
  180. Gulf Biotech
  181. HALIX
  182. Hameln Pharma
  183. Handl Therapeutics
  184. Hansa Biopharma
  185. Hapten Sciences
  186. Health Biotech
  187. Healthcare Pharmaceuticals
  188. Hepalink
  189. Hetero Drugs
  190. Hisun Pharmaceuticals USA
  191. Hookipa Pharma
  192. Hospira One 2 One
  193. Humanigen
  194. Hybio Pharmaceutical
  195. Hycult Biotech
  196. iBio
  197. IDT Biologika
  198. IMA Group
  199. Immune Pharmaceuticals
  200. Immunex
  201. Infectious Disease Research Institute
  202. Injectalia
  203. Intas Pharmaceuticals
  204. Integrity Bio
  205. Irvine Pharmaceutical Services
  206. Istituto Biochimico Italiano Giovanni Lorenzini 
  207. Janssen Pharmaceuticals
  208. JHL Biotech
  209. Jiangsu Yaohai Bio-pharmaceutical
  210. Johnson & Johnson
  211. JOINN Biologics
  212. Jubilant HollisterStier
  213. Kanda BioTech
  214. Kaneka Eurogentec
  215. Kawasaki Heavy Industries
  216. Kaysersberg Pharmaceuticals
  217. Kemwell Biopharma
  218. Klenzaids
  219. Kohlberg and Mubadala
  220. KUKA
  221. Kymanox 
  222. Laboratorios Farmaceuticos ROVI
  223. Laekna Therapeutics
  224. LakePharma
  225. LamKap Bio
  226. Lava Therapeutics
  227. Liof Pharma
  228. Lonza
  229. LSNE Contract Manufacturing
  230. Lubrizol
  231. LuinaBio
  232. LyoGen
  233. Lyophilization Services of New England (LSNE)
  234. Lyophilization Technology
  235. M&O Perry Industries
  236. MabPlex
  237. Madison Dearborn Partners
  238. Marchesini Group
  239. MassBiologics
  240. Massman Automation Designs
  241. MaSTherCell
  242. Masy BioServices
  243. MEDInstill
  244. Merck
  245. Microdermics 
  246. Millmount Healthcare (acquired by PCI Pharma Services)
  247. Miltenyi Biotec
  248. Minaris Regenerative Medicine
  249. Mitsubishi Electric
  250. Moderna
  251. Morgridge Institute for Research (MIR)
  252. Mycenax Biotech
  253. Najít Technologies
  254. National Health Research Institutes (NHRI)
  255. National Institutes of Health
  256. NBE-Therapeutics
  257. Neuma
  258. Nikon CeLL innovation
  259. Ningbo Zhengli Pharmaceutical Packing
  260. Nipro PharmaPackaging
  261. Nitto Avecia Pharma Services
  262. Nitto Denko Avecia
  263. n-Lorem Foundation
  264. Northway Biotechpharma
  265. Nova Laboratories
  266. Novartis
  267. Novasep
  268. Novavax
  269. Noveome Biotherapeutics
  270. Novex Innovations
  271. Novo Nordisk
  272. Nykode (formerly known as Vaccibody)
  273. Ology Bioservices
  274. OmniChem
  275. Ompi
  276. OMRON Industrial Automation
  277. oncomed manufacturing
  278. Oncotec Pharma Produktion
  279. OPKO Health
  280. OPTIMA
  281. Ori Biotech
  282. Oryn Therapeutics
  283. OSO Biopharmaceuticals Manufacturing (acquired by AMRI)
  284. Ottawa Hospital Research Institute
  285. Oxford BioMedica
  286. Pace Analytical Services
  287. PaizaBio
  288. Pall Life Sciences
  289. Panacea Pharmaceuticals
  290. Paragon Bioservices
  291. Particle Measuring Systems (PMS)
  292. Partners Group
  293. Patheon
  294. PCI Pharma Services
  295. Penn Pharmaceutical Services
  296. Permira
  297. Pfizer
  298. Pfizer CentreOne
  299. Pharmaceutical Packaging Professionals
  300. Pharmaceutics International
  301. PharmaTher 
  302. Pierre Fabre
  303. Piramal Pharma Solutions
  304. Polpharma Biologics
  305. Polymun Scientific
  306. Praxis Pharmaceutical
  307. PrimaPharma
  308. Prince Sterilization Services
  309. PSC Biotech
  310. PYRAMID Laboratories
  311. Quality BioResources
  312. QureBio
  313. Recipharm
  314. Regeneron Pharmaceuticals
  315. Reliance Life Sciences
  316. Rentschler Biopharma
  317. Rentschler Fill Solutions
  318. Resilience
  319. Revance Therapeutics
  320. Roche
  321. Romaco
  322. Rommelag CMO
  323. RoslinCT
  324. ROTA
  325. Ruibo Bio-Technology
  326. Russian Direct Investment Fund (RDIF)
  327. Saint-Gobain
  328. Sam Chun Dang Pharm
  329. Samsung Bioepis
  330. Samsung Biologics
  331. Sandoz
  332. Sanofi
  333. Saudi Biotechnology Manufacturing
  334. Schematic Engineering Industries
  335. SCHOTT 
  336. ScinoPharm
  337. Seiko Epson
  338. Selecta Biosciences
  339. Sensorion
  340. Shanghai BravoBio
  341. Sharp 
  342. Shengnuo Peptide
  343. Shenzhen Techdow Pharmaceutical
  344. Sherpa Clinical Packaging (acquired by PCI Pharma Services)
  345. Shibuya
  346. Shree Bhagwati Machtech 
  347. SialoCarb
  348. Siam Bioscience
  349. Siegfried Holding
  350. Singota Solutions
  351. Sio Gene Therapies
  352. SiO2 Medical Products
  353. SIRION Biotech 
  354. Sirton Pharmaceuticals
  355. SKAN
  356. Snowbell Machines
  357. SP
  358. Spanish Agency of Medicines and Medical Devices (AEMPS)
  359. Square Pharmaceuticals
  360. Staubli
  361. Stelis Biopharma
  362. Steriline
  363. Surrozen
  364. Swissfillon
  365. Symbiosis Pharmaceutical
  366. Symphogen
  367. SynCo Bio Partners
  368. Syngene
  369. Synklino
  370. Syntegon
  371. Sypharma
  372. TAIYO Pharma 
  373. Takara Bio
  374. Tanvex BioPharma
  375. Taysha Gene Therapies
  376. Tekpak
  377. ten23 health
  378. The Carlyle Group
  379. Themis
  380. Therapure Biomanufacturing
  381. Theratechnologies
  382. Thermo Fisher Scientific
  383. Tofflon
  384. Transcoject
  385. TransMedics
  386. TriPharm Services (acquired by Alcami)
  387. TRUKING
  388. Tubulis
  389. U.S. Army Contracting Command
  390. UCB
  391. Ultragenyx Pharmaceutical
  392. Universal Robots
  393. University of Queensland
  394. USV
  395. Vaccine and Infectious Disease Organization (VIDO)
  396. Vanrx
  397. Vaxine
  398. VBI Vaccines
  399. Vetter Pharma
  400. VGXI
  401. Vibalogics
  402. Vigene Biosciences
  403. Viralgen
  404. VxP Biologics
  405. WACKER Biotech
  406. Waisman Biomanufacturing
  407. Watson-Marlow Fund
  408. West Pharmaceutical Services
  409. WuXi Biologics
  410. Wuxi Fortune Pharmaceutical
  411. Wuxi Griffin
  412. Yaskawa Electric
  413. Yposkesi

Source 1: https://www.biopharmatrend.com/post/67-will-small-molecules-sustain-pharmaceutical-race-with-biologics/
Source 2: https://www.pharmasalmanac.com/articles/meeting-the-changing-demands-for-sterile-fill-finish-operations

PRICING DETAILS

USD 4,799

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com

This site uses cookies for better browsing experience  Accept

Copyright © 2023 Roots Analysis. All Rights Reserved.